Twenty-four years after breast cancer, one survivor reflects on mammogram anxiety, the relief of clear results and the ...

Eileen Carter was told she had two to three years to live after a stage 4 breast cancer diagnosis. A second opinion changed ...

In a randomized trial of nearly 100,000 women in Germany, 3D mammography found a larger share of breast cancers at the ...

The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Jemperli (dostarlimab) for adults with stage ...

Chester Freeman reflects on hiding the scars from his childhood tumor surgeries for decades and finally feeling comfortable ...

Depending on dose, firmonertinib shrank tumors in 43% to 68% of patients as a first treatment for EGFR PACC-mutant lung ...

The trial added 177Lu-PNT2002 to stereotactic body radiation therapy (SBRT) and found that median progression-free survival ...

Five colorectal cancer trials recently began treating patients, testing targeted drugs, bispecific antibodies and ...

A study of 52,236 patients with cancer found that episodes of unintended weight loss affected 46.63% of patients and were tied to shorter overall survival.

Doctors had found cancer cells in her blood, and further testing confirmed a diagnosis of acute lymphoblastic leukemia (ALL). As 8-year-old Harper Harrell began treatment, much of the childhood she ...

CDK4/6 inhibitors — possible colitis: Ibrance, Kisqali (including the Kisqali Femara Co-Pack) and Verzenio. These pills are ...

From a personalized melanoma vaccine to new options for biliary, stomach, lung and endometrial cancers, here are 5 ESMO 2026 ...